Predictive Mini-bolus Fluid Responsiveness in Pediatric Septic Shock
About the study
Severe sepsis and septic shock remain of particular gravity in children with a current mortality of about 20 % , despite the international prevention campaigns " survival sepsis campaign ". Septic shock associates a macrocirculatory and a microcirculatory dysfunction. The volume expansion remains the treatment of severe sepsis at the initial phase supplemented by the use of vasopressors and / or inotropes. Nevertheless , it is essential to predict the fluid responsiveness after volemic expansion because fluid overload is associated with an increased morbidity in children. In studies , the volume expansion is considered effective if it allows an increase in cardiac output of more than 15 % compared to the basal level. However, their conditions of use remain very restrictive and not applicable to most of our patients ( tidal volume ≥ 7ml / kg , PEEP sufficient , absence of cardiac arrhythmia and effective sedation ) . To date , no index can be used for all patients with invasive mechanical ventilation.
It therefore seems appropriate to develop new tests to predict the response to volume expansion in children with septic shock hospitalized in pediatric intensive care.
A recent study has validated a test to predict the response to volume expansion in adults: injection of a mini-bolus of 50 ml of saline over 10s.
The aim of the study is to evaluate the effect of mini bolus fluid to predict response to fluid expansion in pediatric septic shock.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
- Baby (>28 days) or children < 15 years
- Hospitalisation in paediatric intensive
- Clinico-biological table compatible with severe sepsis or septic shock (likely or documented)
- Requiring the use of invasive mechanical ventilation
- Affiliate or beneficiary of a social security
- Legal guardians Consent Form or Emergency Procedure
EXCLUSION CRITERIA
Exclusion Criteria:
- Any serious hemodynamic clinical situation that would be delayed by inclusion in the protocol
- Patient with shunt heart disease
- Patient in spontaneous or non-invasive ventilation or CPAP
- Patient with a contraindication to volemic/fluid expansion (major cardiac dysfunction, acute renal failure)
- Patient with cardiac arrest upper 5 min
- ECMO
- Postcardiotomia
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Severe Sepsis or Septic Shock in Pediatric Intensive Care Unit
Age (in years)
28 - 15
Phase
Not Applicable
Participants needed
80
Est. Completion Date
Mar 31, 2023
Treatment type
Interventional
Sponsor
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov identifier
NCT04027699
Study number
Precise
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?